How will your role help us transform hope into reality?
The Senior Medical Science Liaison (MSL) is a field-based scientific and clinical expert who strategically supports the medical objectives of Blueprint Medicines’ development programs. You are responsible for identifying, developing, and managing peer-to-peer relationships with a variety of healthcare providers, with a focus on dermatologists in both academic and community practices, but may also include allergists/immunologists, oncologists, hematologists, and gastroenterologists, as appropriate in a multidisciplinary care model.
You will be accountable to engage in high quality scientific exchange about the science and clinical application of our precision medicine portfolio to a variety of external stakeholders, as well as obtain important insights about current practice, treatment landscapes, and emerging clinical and scientific data. In addition, you will be expected to build strong cross-functional relationships, as well as provide meaningful subject-matter expertise, to colleagues in Medical Affairs, Clinical Research, R&D, Patient Advocacy, and Commercial, while maintaining full compliance with all relevant company, industry, legal, and regulatory requirements. You will report to the Regional Director of MSLs.
What will you do?
What minimum qualifications do we require?
What additional qualifications will make you a stronger candidate?
Why Blueprint?
At Blueprint Medicines, patients are our purpose. Their needs ignite our innovation, fuel our urgency and inspire us to go further - faster. We bet on bold people who want to grow, push boundaries and lead meaningful change. Here, you’ll do the most impactful work of your career - because our commitment to changing lives isn’t just what we do, it’s who we are.
Patients are waiting. Are you ready to make the leap?
Compensation and Benefits
The base salary hiring range for this position will be $205,000 -- $265,000.* Actual base salary offered for this position will be based on a number of job-related factors, including, but not limited to: experience (including skills and competencies), education, training and internal equity.
This position is also eligible for the following:
*Based on reasonable estimate for this job at the time of posting; ranges are reviewed periodically and subject to change.
To apply, just scroll down and click on the “Apply Now” link.
Equal Employment Opportunity
At Blueprint Medicines, we foster an environment of fair treatment and full participation for all of our employees as we navigate complex challenges in pursuing our mission to improve the lives of patients. We celebrate our unique differences and varied career and life experiences so that we can sustain our diverse culture and ensure everyone feels accepted. We are committed to non-discrimination, equal employment opportunity, as well as an inclusive recruitment process. We consider all qualified applicants based on merit and without regard to race, color, sex, gender identity, sexual orientation, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, or any other characteristic protected under applicable federal or state law.
We will make reasonable accommodations, absent undue hardship, for qualified individuals with known disabilities. If you are an individual with a disability in need of an accommodation with the application or recruiting process, please reach out to TotalRewards@blueprintmedicines.com. We are also an E-Verify Employer. For more information, please see our EEO Policy Statement, the E-Verify Participation Poster, the Right to Work Poster, and/or the EEO Know Your Rights Poster.
Blueprint Medicines, a Sanofi company, is a global biopharmaceutical company that invents life-changing medicines. We seek to improve and extend patients' lives by solving important medical problems, with a focus on allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a track record of success with two approved medicines, including AYVAKIT/AYVAKYT (avapritinib) which we are bringing to patients with SM in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases and solid tumors. For more information, visit www.BlueprintMedicines.com and follow us on X (formerly Twitter; @BlueprintMeds) and LinkedIn.